Earnings, guidance, and financial announcements. https://www.quantisnow.com/news/financials en-us Sun, 15 Nov 2026 06:20:20 GMT Schall, Brown & Schwartz LLP ("SBS"), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Boeing Company ("Boeing" or "the Company") (NYSE: BA) who received shares in connection with its December 2025 merger ("the Merger") with Spirit AeroSystems Holdings, Inc. ("Spirit") (NYSE:SPR) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Following the Merger with Spirit, shares of Boeing have declined significantly. If you are a shareholder who suffered a loss, cli https://www.quantisnow.com/insight/ba-investors-who-received-shares-of-the-boeing-company-in-6791843 https://www.quantisnow.com/insight/ba-investors-who-received-shares-of-the-boeing-company-in-6791843 Sun, 15 Nov 2026 04:06:00 GMT MIAMI, Nov. 13, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on November 11th by Axe Compute (NASDAQ:AGPU), please note that the date of the conference call in the first paragraph was incorrect. It should have been November 17, 2026, instead of November 16, 2026. The corrected release follows: Axe Compute (NASDAQ:AGPU), a neocloud AI infrastructure company delivering dedicated, bare-metal GPU compute and large-scale AI factory build-outs at global scale, today announced it will hold a conference call and webcast to review financial results for the third quarter ended September 30, 2026, before market open on Tuesday, November 17, 2026. Speakers on the call will be https://www.quantisnow.com/insight/correction-axe-compute-to-host-q3-2026-financial-results-conference-6791836 https://www.quantisnow.com/insight/correction-axe-compute-to-host-q3-2026-financial-results-conference-6791836 Sat, 14 Nov 2026 04:05:00 GMT In the news release, BTQ Technologies to Host Live Webinar on Q3 2026 Financial Results and General Corporate Update, issued Nov. 13, 2026 by BTQ Technologies Corp. over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows: BTQ Technologies to Host Live Webinar on Q3 2026 Financial Results and General Corporate Update VANCOUVER, BC, Nov. 13, 2026 /PRNewswire/ -- BTQ Technologies Corp. ("BTQ" or the "Company") (NASDAQ:BTQ) (CBOE CA: BTQ),  a global technology company building the trust infrastructure for the quantum era, is pleased to announce that it will hold a shareholder call on Friday, November 17, 2026, at 11:00 a.m. EST to disc https://www.quantisnow.com/insight/c-o-r-r-e-c-t-i-o-n-6791662 https://www.quantisnow.com/insight/c-o-r-r-e-c-t-i-o-n-6791662 Fri, 13 Nov 2026 22:00:00 GMT Trinity Place Holdings Inc. (OTC:TPHS) (the "Company," "we," "our," or "us") today announced operating results for the third quarter ended September 30, 2026. The Company is an intellectual property holding, investment, and commercialization company. We own and control a portfolio of intellectual property assets focused on the consumer sector, a legacy of our predecessor, Syms Corp. ("Syms"), including FilenesBasement.com, as well as the intellectual property associated with the Running of the Brides® event and the An Educated Consumer is Our Best Customer® slogan. Our strategy today centers on monetizing these assets through brand licensing, e-commerce initiatives, strategic partnerships https://www.quantisnow.com/insight/trinity-place-holdings-inc-reports-third-quarter-financial-results-6791589 https://www.quantisnow.com/insight/trinity-place-holdings-inc-reports-third-quarter-financial-results-6791589 Fri, 13 Nov 2026 22:49:00 GMT BOISE, Idaho, Nov. 13, 2026 /CNW/ -- Perpetua Resources Corp. (NASDAQ:PPTA) (TSX:PPTA) ("Perpetua Resources" or "Perpetua" or the "Company") announced the filing of its unaudited condensed consolidated financial results for the period ended September 30, 2026. For details, please see the Company's related filing available on EDGAR and SEDAR+. "Perpetua made significant progress in Q3 2026," said Jon Cherry, President and CEO of Perpetua Resources. "From advancing temporary and permanent worker housing to pioneering new access into the site, our Stibnite Gold Project is well positioned to move forward with disciplined execution. https://www.quantisnow.com/insight/perpetua-resources-announces-third-quarter-2026-financial-results-and-provides-6791577 https://www.quantisnow.com/insight/perpetua-resources-announces-third-quarter-2026-financial-results-and-provides-6791577 Fri, 13 Nov 2026 22:40:00 GMT TORONTO, Nov. 13, 2026 /CNW/ -- BMO Asset Management Inc. and BMO Investments Inc. today announced the estimated 2026 annual reinvested distributions for BMO Exchange Traded Funds (BMO ETFs) and ETF Series of BMO Mutual Funds (ETF Series)1. These annual reinvested distributions generally represent realized capital gains and special income within the BMO ETFs and ETF Series, and are paid to unitholders, as required, to ensure that the BMO ETFs and ETF Series are not liable for ordinary income tax. Unitholders of record at close of business on December 30, 2026, will receive the 2026 annual reinvested distributions. The final year-end distribution amounts, as well as the ongoing cash distribut https://www.quantisnow.com/insight/bmo-announces-estimated-annual-reinvested-distributions-for-bmo-exchange-traded-6791555 https://www.quantisnow.com/insight/bmo-announces-estimated-annual-reinvested-distributions-for-bmo-exchange-traded-6791555 Fri, 13 Nov 2026 22:35:00 GMT HOUSTON, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (NASDAQ:CNSY) ("Cerenome" or the "Company"), a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted radiopharmaceuticals, and artificial intelligence, announces financial results for the third quarter ended September 30, 2026, and provides an overview of recent business progress. "Recognition of our first quarter of CNSide® diagnostic revenue and commercial payments beginning in October is a tremendous landmark," said Marc H. Hedrick, M.D., Cerenome’s President and Chief Executive Officer. "Furthermore, our payer universe continues to expand with now about 80% of U.S. private payers https://www.quantisnow.com/insight/cerenome-reports-third-quarter-2026-financial-results-and-business-highlights-6791452 https://www.quantisnow.com/insight/cerenome-reports-third-quarter-2026-financial-results-and-business-highlights-6791452 Fri, 13 Nov 2026 22:19:23 GMT FDA Fast Track Designation for Plinabulin plus docetaxel marks key regulatory milestone in DUBLIN-4 study population of Post-ICI Non-Squamous NSCLC with no actionable genomic alteration (AGA) Strategic transaction with Biolin provides data from approximately half of DUBLIN-4’s 442 patients and supports the planned interim analysis at 221 PFS events FLORHAM PARK, N.J., Nov. 13, 2026 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI) ("BeyondSpring" or the "Company"), a clinical-stage company developing innovative therapies for the treatment of cancer and other diseases, today announced its financial results for the quarter ended September 30, 2026, and provided a corporate update highlig https://www.quantisnow.com/insight/beyondspring-reports-third-quarter-2026-financial-results-and-provides-corporate-update-6791414 https://www.quantisnow.com/insight/beyondspring-reports-third-quarter-2026-financial-results-and-provides-corporate-update-6791414 Fri, 13 Nov 2026 22:15:39 GMT VANCOUVER, BC and GLIL YAM, Israel, Nov. 13, 2026 /PRNewswire/ -- IM Cannabis Corp. (the "Company") (NASDAQ:IMCC) announced its financial results for the third quarter and first nine months ended September 30, 2026. For the third quarter of 2026, revenue totaled C$1.65 million, compared to C$5.08 million in the same period last year. The Company reported a gross loss of C$35,000 and a total net loss of C$7.08 million, compared to a net loss of C$3.87 million in the third quarter of 2025. For the first nine months of 2026, revenue totaled C$8.96 million, compared to C$15.77 million in the corresponding period of 2025, while tota https://www.quantisnow.com/insight/im-cannabis-corp-announces-third-quarter-2026-financial-results-6791389 https://www.quantisnow.com/insight/im-cannabis-corp-announces-third-quarter-2026-financial-results-6791389 Fri, 13 Nov 2026 22:10:00 GMT IRVINE, Calif., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Cheetah Net Supply Chain Service Inc. ("Cheetah" or the "Company") (Nasdaq CM: CTNT), a provider of logistics and warehousing services and international trading services, today reported results for the quarter ended September 30, 2026 and provided a corporate update. For the quarter ended September 30, 2026, the Company reported total revenue of $3,557,805, compared to $361,935 in the same period in 2025, representing an increase of $3,195,870, or 883.0%. The Company recorded an operating loss of $821,890 for the quarter ended September 30, 2026, compared to an operating loss of $1,564,479 in the same period in 2025, representing a decreas https://www.quantisnow.com/insight/cheetah-net-supply-chain-service-inc-announces-third-quarter-2026-6791333 https://www.quantisnow.com/insight/cheetah-net-supply-chain-service-inc-announces-third-quarter-2026-6791333 Fri, 13 Nov 2026 22:05:00 GMT  -     Continued to advance the development of CLD-401 towards the clinic -      Presented new CLD-401 data and in situ TCE platform advances at the ESMO Congress 2026 -      Received $1.2 million gross proceeds from at-the-market registered direct offering -      Reduced general and administrative expenses by $1.0 million, or 39%, in the third quarter of 2026 versus the same period in the prior year SAN DIEGO, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE:CLDI) ("Calidi" or the "Company"), a biotechnology company pioneering the development of targeted genetic medicines, today reported financial and operating results for the three months ended September 30, 2026, https://www.quantisnow.com/insight/calidi-biotherapeutics-reports-third-quarter-2026-financial-results-and-recent-6791324 https://www.quantisnow.com/insight/calidi-biotherapeutics-reports-third-quarter-2026-financial-results-and-recent-6791324 Fri, 13 Nov 2026 22:03:44 GMT VANCOUVER, BC, Nov. 13, 2026 /CNW/ -- BTQ Technologies Corp. ("BTQ" or the "Company") (NASDAQ:BTQ) (CBOE CA: BTQ),  a global technology company building the trust infrastructure for the quantum era, is pleased to announce that it will hold a shareholder call on Friday, August 14, 2026, at 12:00 p.m. EST to discuss its quarterly financial results and provide a general corporate update. The call will follow the release of the Company's Q3 2026 financial statements, which will be issued after market close on Monday, November 16, 2026. IMPORTANT – To register for the webcast see below:When: November 17, 2026Time: 11:00 AM Eastern T https://www.quantisnow.com/insight/btq-technologies-to-host-live-webinar-on-q3-2026-financial-6791274 https://www.quantisnow.com/insight/btq-technologies-to-host-live-webinar-on-q3-2026-financial-6791274 Fri, 13 Nov 2026 22:00:00 GMT GREENWICH, Conn., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Stardust Power Inc. ("Stardust Power" or the "Company"), an American developer of battery-grade lithium carbonate, today announced its financial results for the quarter ended September 30, 2026, and provided an update on its corporate developments and the development of its proposed lithium refinery project in Muskogee, Oklahoma. Third Quarter 2026 Business Updates and Subsequent Events: Muskogee Lithium Refinery: The Company continued to test soil core samples taken from its Muskogee, Oklahoma site as part of the Company’s third-party geotechnical evaluation of site conditions. The proposed refinery project is designed for a nameplate https://www.quantisnow.com/insight/stardust-power-reports-q3-2026-financial-results-and-business-update-6791268 https://www.quantisnow.com/insight/stardust-power-reports-q3-2026-financial-results-and-business-update-6791268 Fri, 13 Nov 2026 22:00:00 GMT –First Quarter Revenue Increased 27% Year-over-Year to $5.4 Million; Revenue Plus Interest Income of $5.9 Million*– –Stock Locate Revenue of $3.0 Million– –Revenue from Sources Other Than Commissions Rose to 68% of Total Revenue, from 45%– –AtlasClearing Net Capital Increased to $15.2 Million, $14.9 Million in Excess of Requirements– –Definitive Agreement to Acquire Ark Financial Services Signed and FINRA Continuing Membership Application Filed; Correspondent Network Expanded to Nine Signed Agreements– –Earnings Conference Call Scheduled for Monday, November 16, 2026, at 8:30 AM ET– TAMPA, Fla., Nov. 13, 2026 (GLOBE NEWSWIRE) -- AtlasClear Holdings, Inc. ("AtlasClear" or the "Company https://www.quantisnow.com/insight/atlasclear-holdings-inc-reports-fiscal-first-quarter-2027-results-6791224 https://www.quantisnow.com/insight/atlasclear-holdings-inc-reports-fiscal-first-quarter-2027-results-6791224 Fri, 13 Nov 2026 21:52:53 GMT Seritage Growth Properties (NYSE:SRG) (the "Company"), a national owner and developer of retail, residential and mixed-use properties today reported financial and operating results for the three and nine months ended September 30, 2026. "Although we have no new transactions under contract, we continue to work on both individual asset sales and potential strategic options for the portfolio and the Company," said Adam Metz, CEO & President. Q3 Sale Highlights: Generated gross proceeds of $3.0 million from the sale of one vacant/non-income producing asset and received a distribution of $8.9 million from an unconsolidated entity as a result of the sale of a portion of the underlying prop https://www.quantisnow.com/insight/seritage-growth-properties-reports-third-quarter-2026-operating-results-6791202 https://www.quantisnow.com/insight/seritage-growth-properties-reports-third-quarter-2026-operating-results-6791202 Fri, 13 Nov 2026 21:50:00 GMT The Eagle Capital Growth Fund, Inc. ("Fund") (NYSE:GRF) today declared a year-end distribution of $0.49 per share in cash. The record date for this distribution is November 27, 2026, and the payment date is December 17, 2026. On a preliminary basis, this distribution represents a combination of net investment income of $0.055 per share and long-term capital gains of $0.435 per share. All of the net investment income consists of "qualified" dividends. This preliminary information is subject to change. Shareholders will receive definitive information with respect to U.S. Federal income tax treatment. In addition, shareholders can access definitive tax information by going to the Fund’s webs https://www.quantisnow.com/insight/eagle-capital-growth-fund-declares-year-end-distribution-of-049-per-6791185 https://www.quantisnow.com/insight/eagle-capital-growth-fund-declares-year-end-distribution-of-049-per-6791185 Fri, 13 Nov 2026 21:49:00 GMT Exclusively licensed Senlang’s CD7-Targeted lentiviral in vivo CAR-T platform following initial Phase 1 results with lead BCMA/GPRC5D candidate TPST-4903 Secured access to additional capital through an equity line of credit with Lincoln Park Capital Fund of up to $50.0 million and a private placement with gross proceeds of approximately $2.5 million Strengthened Board of Directors with the appointments of Nancy Freda-Smith and John W. Frederick BRISBANE, Calif., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST) ("Tempest"), a clinical-stage biotechnology company developing a pipeline of advanced in vivo chimeric antigen receptor T-cell ("CAR-T") product candida https://www.quantisnow.com/insight/tempest-reports-third-quarter-2026-financial-results-and-provides-business-6791175 https://www.quantisnow.com/insight/tempest-reports-third-quarter-2026-financial-results-and-provides-business-6791175 Fri, 13 Nov 2026 21:47:59 GMT Manufacturing Work Addressing FDA CMC Information Requests Substantially Completed NDA Resubmission Expected Between December 2026 and January 2027 KANSAS CITY, Kan., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to develop a pipeline of next-generation products, today reported financial results for the quarter ended September 30, 2026, and announced that it has substantially completed the manufacturing work required to address the U.S. Food and Drug Administration’s (FDA) chemistry, manufacturing and controls (CMC) information requests for CTx-1301. The Company https://www.quantisnow.com/insight/cingulate-inc-reports-third-quarter-2026-financial-results-and-provides-6791148 https://www.quantisnow.com/insight/cingulate-inc-reports-third-quarter-2026-financial-results-and-provides-6791148 Fri, 13 Nov 2026 21:45:00 GMT HOUSTON, Nov. 13, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Westlake Corporation (NYSE:WLK) today declared a regular dividend distribution of $0.533 per share for the third quarter of 2026. This dividend will be payable on December 10, 2026 to stockholders of record on November 24, 2026. Westlake announced its first dividend on November 11, 2004 and has successively been paying and increasing its dividend for the past 22 years. The statements in this release that are not historical facts, including statements regarding future payment of dividend, are forward-looking statements. These forward-looking statements are subject to significant risks and uncertainties. For more detailed https://www.quantisnow.com/insight/westlake-corporation-declares-quarterly-dividend-6791097 https://www.quantisnow.com/insight/westlake-corporation-declares-quarterly-dividend-6791097 Fri, 13 Nov 2026 21:40:00 GMT LOS ANGELES, Nov. 13, 2026 (GLOBE NEWSWIRE) -- XMax Inc. (NASDAQ:XMAX, "XMAX" or the "Company")), a distributor of contemporary furniture and artificial intelligence software and platform-based service provider, today announced financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Financial Highlights Revenue: $6.4 million, down 34% from $9.8 million in the third quarter of 2025, including $4.5 million from API-based services and $1.9 million from furniture (down 81%, as the prior-year period included a $7.9 million marble slab liquidation sale)Gross Profit: $0.9 million, representing a 14% gross margin, compared to gross profit of $1.0 million and gross ma https://www.quantisnow.com/insight/xmax-inc-announces-third-quarter-2026-financial-results-6791044 https://www.quantisnow.com/insight/xmax-inc-announces-third-quarter-2026-financial-results-6791044 Fri, 13 Nov 2026 21:35:00 GMT HOUSTON, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) today announced that the Board of Directors declared a quarterly cash dividend of $0.55 per share, payable on January 29, 2027, to common stockholders of record at the close of business on January 8, 2027. About Sysco Sysco is the global leader in selling, marketing and distributing food and related products to customers who prepare meals away from home. This includes restaurants, healthcare and educational facilities, lodging establishments, entertainment venues, and more. Sysco operates 333 distribution centers, in 10 countries, with 75,000 colleagues serving approximately 670,000 customer locations. The company ge https://www.quantisnow.com/insight/sysco-declares-quarterly-dividend-payment-6791043 https://www.quantisnow.com/insight/sysco-declares-quarterly-dividend-payment-6791043 Fri, 13 Nov 2026 21:35:00 GMT SEATTLE, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Parabolic Technologies, Inc. (NASDAQ:PARA) (the "Company"), a leading AI-powered agentic applications technology company, will hold a conference call on Monday, November 16, 2026, at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter ended September 30, 2026, as well as review ongoing initiatives and anticipated milestones. Parabolic Founder and CEO Joe Davy and CFO Dean Ditto will host the conference call, followed by a question-and-answer session. The conference call will be accompanied by a presentation, which can be viewed during the webcast or accessed via the investor relations section of the Company’s website h https://www.quantisnow.com/insight/parabolic-technologies-inc-to-host-third-quarter-2026-financial-results-6790967 https://www.quantisnow.com/insight/parabolic-technologies-inc-to-host-third-quarter-2026-financial-results-6790967 Fri, 13 Nov 2026 21:32:43 GMT MOORESVILLE, N.C., Nov. 13, 2026 /PRNewswire/ -- The board of directors of Lowe's Companies, Inc. (NYSE:LOW) has declared a quarterly cash dividend of one dollar and 25 cents ($1.25) per share, payable Feb. 3, 2027, to shareholders of record as of Jan. 20, 2027.  About Lowe'sLowe's Companies, Inc. (NYSE:LOW) is a FORTUNE® 100 home improvement company with total fiscal 2025 sales of more than $86 billion. Lowe's employs approximately 300,000 associates and operates over 1,750 home improvement stores, 540 branches and 120 distribution centers. Lowe's is a core value S&P 500 equity stock, a dividend aristocrat and dividend king. B https://www.quantisnow.com/insight/lowes-companies-inc-declares-cash-dividend-6790899 https://www.quantisnow.com/insight/lowes-companies-inc-declares-cash-dividend-6790899 Fri, 13 Nov 2026 21:30:00 GMT Morgan Stanley today declared a regular dividend on the outstanding shares of each of the following preferred stock issues: Floating Rate Non-Cumulative Preferred Stock, Series A - $319.71 per share (equivalent to $0.319706 per Depositary Share) 10 Percent Non-Cumulative Non-Voting Perpetual Preferred Stock, Series C - $25.00 per share Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series E - $455.21 per share (equivalent to $0.455208 per Depositary Share) Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series F - $439.24 per share (equivalent to $0.439236 per Depositary Share) Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series I - $407.29 pe https://www.quantisnow.com/insight/morgan-stanley-declares-dividends-on-its-preferred-stock-6790898 https://www.quantisnow.com/insight/morgan-stanley-declares-dividends-on-its-preferred-stock-6790898 Fri, 13 Nov 2026 21:30:00 GMT Growth in Advisory, Principal Transactions; Retail Accounts and Customer Net Worth Continue to Increase Siebert Financial Corp. (NASDAQ:SIEB) ("Siebert"), a diversified provider of financial services, today reported financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Financial and Operational Highlights* Advisory fees increased 38% to $1.1 million, compared with $0.8 million in the prior-year quarter. Principal transaction revenue increased 8% to $4.7 million, compared with $4.3 million in the prior-year quarter, primarily due to market conditions. Commissions and fees increased 5% to $2.4 million, compared with $2.3 million in the prior-year qu https://www.quantisnow.com/insight/siebert-reports-third-quarter-2026-financial-results-6790897 https://www.quantisnow.com/insight/siebert-reports-third-quarter-2026-financial-results-6790897 Fri, 13 Nov 2026 21:30:00 GMT Cathay General Bancorp (NASDAQ:CATY) announced that its Board of Directors declared a cash dividend of thirty-eight cents per common share, payable on December 7, 2026, to stockholders of record at the close of business on November 27, 2026. ABOUT CATHAY GENERAL BANCORP Cathay General Bancorp (NASDAQ:CATY) is the holding company for Cathay Bank. Cathay General Bancorp’s website is at www.cathaygeneralbancorp.com. Founded in 1962, Cathay Bank offers a wide range of financial services and currently operates over 60 branches across the nation in California, New York, Washington, Texas, Illinois, Massachusetts, Maryland, Nevada, and New Jersey. Overseas, it has a branch in Hong Kong, and re https://www.quantisnow.com/insight/cathay-general-bancorp-declares-038-per-share-dividend-6790896 https://www.quantisnow.com/insight/cathay-general-bancorp-declares-038-per-share-dividend-6790896 Fri, 13 Nov 2026 21:30:00 GMT CARLSBAD, Calif., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (NASDAQ:NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, announced today a net loss of $2.5 million, or ($0.41) per diluted share, on net sales of $28.1 million for the first quarter of fiscal year 2027 compared to a net loss of $0.3 million, or ($0.05) per diluted share, in the first quarter of the prior fiscal year. Net sales during the three months ended September 30, 2026, decreased $9.6 million, or 25.5%, to $28.1 million compared to $37.7 million recorded in the comparable prior year period. During the same period, private-label contract https://www.quantisnow.com/insight/natural-alternatives-international-inc-announces-fiscal-2027-q1-results-6790895 https://www.quantisnow.com/insight/natural-alternatives-international-inc-announces-fiscal-2027-q1-results-6790895 Fri, 13 Nov 2026 21:30:00 GMT CLEVELAND, Nov. 13, 2026 /PRNewswire/ -- KeyCorp (NYSE:KEY) announced today that it has provided notice of its intention to redeem all 20,000,000 depositary shares each representing a 1/40th ownership interest in a share of its issued and outstanding Series E Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock (NYSE:KEY, CUSIP No. 493267702)) (the "Preferred Stock") on December 15, 2026.There are 20,000,000 depositary shares representing 500,000 shares of Preferred Stock, with an aggregate liquidation preference of $500,000,000, currently outstanding. The Preferred Stock will be redeemed for cash at the redemption price of $1,015.3125 per share ($25.3828125 per depositary share), https://www.quantisnow.com/insight/keycorp-provides-notice-of-redemption-of-series-e-preferred-stock-6790861 https://www.quantisnow.com/insight/keycorp-provides-notice-of-redemption-of-series-e-preferred-stock-6790861 Fri, 13 Nov 2026 21:27:00 GMT JPMorgan Chase & Co. (NYSE:JPM) ("JPMorganChase" or the "Firm") has declared dividends on the outstanding shares of the Firm’s Series II, OO and PP preferred stock. Information can be found on the Firm’s Investor Relations website at https://www.jpmorganchase.com/ir/news. JPMorgan Chase & Co. (NYSE:JPM) is a leading financial services firm based in the United States of America ("U.S."), with operations worldwide. JPMorganChase had $5.1 trillion in assets and $372 billion in stockholders’ equity as of September 30, 2026. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset managemen https://www.quantisnow.com/insight/jpmorganchase-declares-preferred-stock-dividends-6790785 https://www.quantisnow.com/insight/jpmorganchase-declares-preferred-stock-dividends-6790785 Fri, 13 Nov 2026 21:20:00 GMT ATLANTA, Nov. 13, 2026 /PRNewswire/ -- Invesco Mortgage Capital Inc. (NYSE:IVR) (the "Company") today announced that the Company declared a cash dividend of $0.12 per share of common stock for the month of November 2026. The dividend will be paid on December 14, 2026 to stockholders of record at the close of business on November 24, 2026, with an ex-dividend date of November 24, 2026. Financial Highlights as of October 31, 2026Total investment portfolio including TBAs of $8.1 billionUnrestricted cash and unencumbered securities of $413.2 million(1)Total repurchase agreement borrowings of $6.7 billionEstimated book value per com https://www.quantisnow.com/insight/invesco-mortgage-capital-inc-november-2026-dividend-announcement-and-october-6790690 https://www.quantisnow.com/insight/invesco-mortgage-capital-inc-november-2026-dividend-announcement-and-october-6790690 Fri, 13 Nov 2026 21:15:00 GMT CARMEL, Ind., Nov. 13, 2026 /PRNewswire/ -- CNO Financial Group, Inc. (NYSE:CNO) announced today that its Board of Directors has declared a quarterly cash dividend of $0.18 per share on the company's common shares. This marks the 59th consecutive quarterly dividend paid by the company. The dividend will be payable December 23, 2026, to shareholders of record at the close of business on December 10, 2026. About CNO Financial GroupCNO Financial Group, Inc. (NYSE:CNO) secures the future of middle-income America. CNO provides life and health insurance, annuities and financial services through our family of brands, including Bankers https://www.quantisnow.com/insight/cno-financial-group-declares-018-quarterly-dividend-6790689 https://www.quantisnow.com/insight/cno-financial-group-declares-018-quarterly-dividend-6790689 Fri, 13 Nov 2026 21:15:00 GMT Boston Omaha Corporation (NYSE:BOC) (the "Company", "we", or "our") announced its financial results for the third quarter ended September 30, 2026, in connection with filing its Quarterly Report on Form 10-Q with the Securities and Exchange Commission. We show summary financial data below for the third quarter of 2026 and 2025. Our Quarterly Report on Form 10-Q can be found at www.bostonomaha.com. A supplemental presentation providing additional financial information for the third quarter of 2026 can be found on our investor relations website at https://investor.bostonomaha.com. We believe that it is important for shareholders to read the supplemental presentation as, in management’s opin https://www.quantisnow.com/insight/boston-omaha-corporation-announces-third-quarter-2026-financial-results-and-6790686 https://www.quantisnow.com/insight/boston-omaha-corporation-announces-third-quarter-2026-financial-results-and-6790686 Fri, 13 Nov 2026 21:15:00 GMT American Strategic Investment Co. (NYSE:NYC) ("ASIC" or the "Company"), a company that owns a portfolio of commercial real estate located within the five boroughs of New York City, announced today its financial and operating results for the third quarter ended September 30, 2026. Third Quarter 2026 Highlights Revenue was $7.1 million compared to $12.3 million in the third quarter of 2025, primarily related to the disposition of 1140 Avenue of the Americas in the prior year Net loss attributable to common stockholders was $6.7 million, compared to net income of $35.8 million in the third quarter of 2025 that was primarily due to a non-cash gain recognized in connection with the dispo https://www.quantisnow.com/insight/american-strategic-investment-co-announces-third-quarter-2026-results-6790683 https://www.quantisnow.com/insight/american-strategic-investment-co-announces-third-quarter-2026-results-6790683 Fri, 13 Nov 2026 21:15:00 GMT The Board of Directors of Xylem Inc. (NYSE:XYL) has declared a fourth quarter dividend of $0.43 per share payable on December 22, 2026, to shareholders of record as of November 24, 2026. About Xylem Xylem (XYL) is a Fortune 500 global water solutions company that empowers customers and communities to build a more water-secure world. Our 22,000 employees delivered revenue of $9 billion in 2025, optimizing water and resource management with innovation and expertise. Join us at www.xylem.com and Let’s Solve Water. Xylem uses our Investor Relations website, www.xylem.com/en-us/investors, as a means of disclosing information which may be of interest or material to our investors and for com https://www.quantisnow.com/insight/xylem-declares-fourth-quarter-dividend-of-43-cents-per-share-6790682 https://www.quantisnow.com/insight/xylem-declares-fourth-quarter-dividend-of-43-cents-per-share-6790682 Fri, 13 Nov 2026 21:15:00 GMT Maroussi, Greece, November 13, 2026 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), an international diversified shipping company with a focus on the seaborne transportation of refined petroleum products and dry bulk commodities, today announced the following: We will issue our unaudited results for the third quarter ended September 30, 2026, after the market close in New York on Monday, November 30, 2026. An accompanying slide presentation of the third quarter 2026 financial results will be available on the Pyxis Tankers website, under the Presentations section of the Investor Relations page. About Pyxis Tankers Inc. Pyxis Tankers Inc. currently owns a modern fleet of six mid-sized eco-ves https://www.quantisnow.com/insight/pyxis-tankers-announces-date-for-the-release-of-the-third-6790681 https://www.quantisnow.com/insight/pyxis-tankers-announces-date-for-the-release-of-the-third-6790681 Fri, 13 Nov 2026 21:15:00 GMT Scholar Rock (NASDAQ:SRRK, the "Company")) today announced that the company granted inducement equity awards covering an aggregate of 39,587 shares of its common stock to six newly hired employees, consisting of inducement stock options to purchase an aggregate of 11,349 shares of common stock and inducement restricted stock units, covering an aggregate of 28,238 shares of its common stock. The awards are subject to all terms and conditions and other provisions set forth in the Company’s 2022 Inducement Equity Plan (the "Plan") and the award agreements thereunder. The Plan, initially adopted by the Company’s board of directors on June 16, 2022, and as amended from time to time, is used https://www.quantisnow.com/insight/scholar-rock-reports-new-employee-inducement-grants-under-nasdaq-listing-6790680 https://www.quantisnow.com/insight/scholar-rock-reports-new-employee-inducement-grants-under-nasdaq-listing-6790680 Fri, 13 Nov 2026 21:15:00 GMT ATLANTA, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Atlanticus Holdings Corporation (NASDAQ:ATLC) ("Atlanticus," the "Company," "we," "our" or "us"), a financial technology company that enables its bank, retail and healthcare partners to offer more inclusive financial services to millions of everyday Americans, today announced that its Board of Directors approved a quarterly dividend of $0.476563 per share to Series B Cumulative Perpetual Preferred shareholders. The cash dividend will be paid on or about December 15, 2026 to holders of record of Atlanticus’ Series B Cumulative Perpetual Preferred Stock on the close of business on December 1, 2026. About Atlanticus Holdings Corporation Empowering https://www.quantisnow.com/insight/atlanticus-announces-approval-of-quarterly-preferred-stock-dividend-6790678 https://www.quantisnow.com/insight/atlanticus-announces-approval-of-quarterly-preferred-stock-dividend-6790678 Fri, 13 Nov 2026 21:15:00 GMT Millicom (Tigo) signs agreement to acquire Entel Peru, expanding its presence across Latin America The transaction expands Millicom’s presence in investment-grade markets and is expected to be accretive to equity free cash flow in the first year following completion. Closing is expected in early December, subject to customary closing conditions.    Luxembourg, November 13, 2026 – Millicom (NASDAQ:TIGO) today announced that it has signed an agreement to acquire Entel Peru for US$1,714 million, including lease liabilities, implying a transaction multiple of 5.0x estimated 2026 EBITDA, before synergies and integration costs. This transaction marks another important step in Millicom's regiona https://www.quantisnow.com/insight/millicom-tigo-signs-agreement-to-acquire-entel-peru-expanding-its-6790592 https://www.quantisnow.com/insight/millicom-tigo-signs-agreement-to-acquire-entel-peru-expanding-its-6790592 Fri, 13 Nov 2026 21:09:06 GMT TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ:TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the three months ended September 30, 2026. Third Quarter 2026 Financial Results Net Income from Continuing Operations Net income from continuing operations totaled $501 thousand, or $0.04 per basic and diluted common share, compared to income from continuing operations of $50 thousand, or $0.00 per basic and diluted common share for the third quarter of 2025. License Revenues from Continuing Operations The Company recorded $1.3 million in license revenue for the third quarter of 2026, an increase of $475 thousand, o https://www.quantisnow.com/insight/therapeuticsmd-announces-third-quarter-2026-financial-results-6790455 https://www.quantisnow.com/insight/therapeuticsmd-announces-third-quarter-2026-financial-results-6790455 Fri, 13 Nov 2026 21:05:00 GMT The Badger Meter, Inc. (NYSE:BMI) Board of Directors today declared a regular quarterly cash dividend of $0.44 per share to shareholders of record on November 30, 2026, payable December 11, 2026. In addition, the Board approved an additional share repurchase authorization for up to $250 million of the Company’s outstanding common stock. The share repurchase authorization expands the existing authorization approved by the Board in November 2025, and increased in February 2026, all of which are set to expire in November 2029. The additional share repurchase program authorizes the Company to purchase shares from time to time in the open market, through privately negotiated transactions, or https://www.quantisnow.com/insight/badger-meter-declares-regular-quarterly-dividend-and-expands-share-repurchase-6790453 https://www.quantisnow.com/insight/badger-meter-declares-regular-quarterly-dividend-and-expands-share-repurchase-6790453 Fri, 13 Nov 2026 21:05:00 GMT Broadway Financial Corporation ("Broadway", "we", or the "Company") (NASDAQ:BYFC), parent company of City First Bank, National Association (the "Bank", and collectively, with the Company, "City First Broadway"), reported net income attributable to common stockholders of $392 thousand during the third quarter of 2026, compared to net income attributable to common stockholders of $218 thousand for the second quarter of 2026, and net loss attributable to common stockholders of $24.6 million for the third quarter of 2025. Diluted earnings (loss) per common share was $0.04 for the third quarter of 2026, compared to $0.02 for the second quarter of 2026 and ($2.86) for the third quarter of 2025. https://www.quantisnow.com/insight/broadway-financial-corporation-reports-third-quarter-2026-results-highlighted-by-6790452 https://www.quantisnow.com/insight/broadway-financial-corporation-reports-third-quarter-2026-results-highlighted-by-6790452 Fri, 13 Nov 2026 21:05:00 GMT EB-003 Development Highlights: Advancing final IND-enabling activities to support the planned EB-003 IND application Completed IND-enabling absorption and metabolic studies with favorable findings supporting EB-003’s potential for reduced drug-drug interactions Reported preclinical qEEG results demonstrating brain penetration and activity distinct from DMT, supporting evaluation as a potential biomarker Reported in vitro mechanistic studies, supporting EB-003’s predicted non-hallucinogenic profile Corporate and Business Development Highlights: Secured U.S. patent allowance for next-generation, non-hallucinogenic mescaline derivatives in EVM401 Series Supported the FDA r https://www.quantisnow.com/insight/enveric-biosciences-reports-financial-results-for-third-quarter-2026-and-6790451 https://www.quantisnow.com/insight/enveric-biosciences-reports-financial-results-for-third-quarter-2026-and-6790451 Fri, 13 Nov 2026 21:05:00 GMT ROLR™ prediction markets platform launched to the public on October 21 and began generating revenue in the fourth quarter; the ROLR iOS app has been available in the Apple App Store since November 9No outstanding borrowings and $13.4 million in cash and cash equivalents at September 30, 2026Conference call today, November 13, at 4:30 p.m. ET LAS VEGAS, Nevada, Nov. 13, 2026 (GLOBE NEWSWIRE) -- High Roller Technologies, Inc. ("High Roller" or the "Company") (NYSE:ROLR), a prediction markets and online gaming company, today reported its financial results for the third quarter ended September 30, 2026, and provided an update on the commercial launch and continued development of its ROLR™ pre https://www.quantisnow.com/insight/high-roller-technologies-reports-third-quarter-2026-results-and-highlights-6790450 https://www.quantisnow.com/insight/high-roller-technologies-reports-third-quarter-2026-results-and-highlights-6790450 Fri, 13 Nov 2026 21:05:00 GMT SARATOGA SPRINGS, N.Y., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Espey Mfg. & Electronics Corp. (NYSE:ESP) announces results for the first three months of fiscal year 2027. Net sales for the three months ended September 30, 2026 and 2025 were $10,608,945 and $9,092,876, respectively. Net income for the three months ended September 30, 2026 was $2,189,509 or $0.77 and $0.75 per share, basic and diluted, compared to net income of $2,169,836 or $0.80 and $0.76 per share, basic and diluted, for the three months ended September 30, 2025. The total backlog at September 30, 2026 was $126.7 million, compared to approximately $141.1 million at September 30, 2025. New orders received in the first three m https://www.quantisnow.com/insight/espey-mfg-electronics-corp-reports-first-quarter-results-6790448 https://www.quantisnow.com/insight/espey-mfg-electronics-corp-reports-first-quarter-results-6790448 Fri, 13 Nov 2026 21:05:00 GMT NEW YORK, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (NASDAQ:INDP) ("Indaptus" or the "Company"), a biotechnology company dedicated to immunotherapy research, today announced financial results for the third quarter and nine months ended September 30, 2026, and provided a corporate update.Junyi Dai, Indaptus Therapeutics’ Chief Executive Officer and Chairman of the Board, commented, "Our strategic objective is to position Indaptus for its next phase of growth by actively pursuing innovative opportunities with significant long-term potential and expanding the Company’s strategic focus into promising areas of medical innovation. We believe the successful completion of our a https://www.quantisnow.com/insight/indaptus-therapeutics-reports-third-quarter-2026-financial-results-and-provides-6790447 https://www.quantisnow.com/insight/indaptus-therapeutics-reports-third-quarter-2026-financial-results-and-provides-6790447 Fri, 13 Nov 2026 21:05:00 GMT SANTA CRUZ, Calif., Nov. 13, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of West Coast Community Bancorp (the "Company") (NASDAQ:WCCB), the parent company of West Coast Community Bank, announced the approval of a new share repurchase program. Under the share repurchase program, the Company is authorized to repurchase up to $25 million of the Company’s common stock in the open market or through privately negotiated transactions as market conditions warrant. The program does not obligate the Company to repurchase any specified number of shares. The timing and price of repurchases as well as the actual number of shares repurchased under the program will be at the discretion of the Compan https://www.quantisnow.com/insight/west-coast-community-bancorp-announces-share-repurchase-program-6790443 https://www.quantisnow.com/insight/west-coast-community-bancorp-announces-share-repurchase-program-6790443 Fri, 13 Nov 2026 21:05:00 GMT ATLANTA, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator developing transformative fertility and non-surgical permanent birth control solutions designed to improve the standard of care, expand access, and reduce costs for women worldwide, announces its financial results for the quarter ended September 30, 2026 and provides a corporate update. Corporate Highlights from 3Q 2026 to date Completed $30 million private placement with potential total proceeds of up to $85 million upon full cash exercise of warrants, to build-out the U.S. commercial team needed to support revenue growth following recent availability of the FemaSeed® fertility portfoli https://www.quantisnow.com/insight/femasys-announces-financial-results-for-quarter-ended-september-30-2026-6790439 https://www.quantisnow.com/insight/femasys-announces-financial-results-for-quarter-ended-september-30-2026-6790439 Fri, 13 Nov 2026 21:05:00 GMT SAN DIEGO, Nov. 13, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (NASDAQ:INBX) (Inhibrx or the Company) today reported financial results for the third quarter of 2026. The biopharmaceutical company has two programs in ongoing clinical trials. Upcoming Clinical MilestonesOzekibart (INBRX-109) in Ewing sarcoma. The Company plans to present updated results from the Phase 1/2 study evaluating ozekibart (INBRX-109) in combination with irinotecan and temozolomide in refractory Ewing sarcoma at the annual Connective Tissue Oncology Society (CTOS) meeting in Seoul, South Korea from November 19th-20th, 2026.Ozekibart (INBRX-109) in Ch https://www.quantisnow.com/insight/inhibrx-reports-third-quarter-2026-financial-results-6790373 https://www.quantisnow.com/insight/inhibrx-reports-third-quarter-2026-financial-results-6790373 Fri, 13 Nov 2026 21:02:00 GMT Positive Phase 1a results for TRB-061 support proof of mechanism, with topline Phase 1b data in atopic dermatitis expected in mid-2027TRB-071 advancing through IND-enabling studies, with Phase 1 trial initiation expected in the first half of 2027Completed a $133.5 million initial public offering in October 2026, extending expected cash runway into the second half of 2029 SOUTH SAN FRANCISCO, Calif., Nov. 13, 2026 (GLOBE NEWSWIRE) -- TRex Bio, Inc. ("TRexBio") (NASDAQ:TRXB), a clinical-stage biotechnology company focused on tissue Treg biology for the discovery and development of immunoregulatory medicines, today reported financial results for the third quarter ended September 30, 2026, an https://www.quantisnow.com/insight/trexbio-reports-third-quarter-2026-financial-results-and-recent-business-6790352 https://www.quantisnow.com/insight/trexbio-reports-third-quarter-2026-financial-results-and-recent-business-6790352 Fri, 13 Nov 2026 21:02:00 GMT WAUWATOSA, Wis., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Waterstone Financial, Inc. (NASDAQ:WSBF), holding company for WaterStone Bank, reported net income of $6.2 million, or $0.36 per diluted share, for the quarter ended September 30, 2026 compared to $7.9 million, or $0.45 per diluted share, for the quarter ended September 30, 2025. Net income totaled $20.6 million for the nine months ended September 30, 2026 compared to net income of $18.7 million for the nine months ended September 30, 2025. Net income per diluted share was $1.19 for the nine months ended September 30, 2026 compared to net income per diluted share of $1.04 for the nine months ended September 30, 2025. "We are pleased with https://www.quantisnow.com/insight/waterstone-financial-inc-announces-results-of-operations-for-the-quarter-6790334 https://www.quantisnow.com/insight/waterstone-financial-inc-announces-results-of-operations-for-the-quarter-6790334 Fri, 13 Nov 2026 21:01:00 GMT